Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO) Source: ERJ Open Res, 8 (1) 00610-2021; 10.1183/23120541.00610-2021 Year: 2022
Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Evaluation of ICS/LABA combination therapy on respiratory function in patients with asthma: Open-label, randomized, cross-over trial. Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018
The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial Source: Eur Respir J, 51 (2) 1701488; 10.1183/13993003.01488-2017 Year: 2018
Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT? Source: ERJ Open Res 2016: 00055-2016 Year: 2016
Azithromycin and Hydroxychloroquine in hospitalized patients with confirmed SARS-CoV-2 infection - a randomized placebo-controlled trial (ProPAC-COVID Trial) Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021
Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018 Year: 2019
Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial Source: Eur Respir J 2001; 17: 206-213 Year: 2001
Effectiveness of a pharmacist intervention for asthma control improvement: randomised controlled trial Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care Year: 2007
Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021
Efficiency of physiotherapy with Caycedian Sophrology on children with asthma: a randomized controlled trial. Source: International Congress 2018 – Paediatric asthma: new insights in its prevalence, treatment and treatment failure Year: 2018
Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial Source: Eur Respir J, 49 (6) 1700561; 10.1183/13993003.00561-2017 Year: 2017
Run-in bias in randomised trials: the case of COPD medications Source: Eur Respir J, 49 (6) 1700361; 10.1183/13993003.00361-2017 Year: 2017
A self-management programme for COPD: a randomised controlled trial Source: Eur Respir J 2014; 44: 1538-1547 Year: 2014
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial Source: Eur Respir J, 59 (1) 2100752; 10.1183/13993003.00752-2021 Year: 2022
Effectiveness of a multi-component intensive smoking cessation programme for COPD outpatients: A randomized controlled trial Source: Annual Congress 2003 - COPD and smoking (cessation) Year: 2003
Experimental hookworm infection as potential therapy for asthma: a randomised placebo controlled trial Source: Annual Congress 2009 - Epidemiology of atopy and asthma Year: 2009
No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial Source: ERJ Open Res, 6 (4) 00342-2020; 10.1183/23120541.00342-2020 Year: 2020